Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2005-08-04
2010-06-01
Berch, Mark L (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C514S251000
Reexamination Certificate
active
07728134
ABSTRACT:
Disclosed are hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]Amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide:processes for preparing them and their use as pharmaceutical compositions with antiproliferative activity.
REFERENCES:
patent: 4957922 (1990-09-01), Lammens et al.
patent: 5167949 (1992-12-01), Ferrand et al.
patent: 5424311 (1995-06-01), Billhardt-Troughton et al.
patent: 5698556 (1997-12-01), Grauert et al.
patent: 6174895 (2001-01-01), Kleinman
patent: 6605255 (2003-08-01), Kroll et al.
patent: 6806272 (2004-10-01), Bauer et al.
patent: 6861422 (2005-03-01), Hoffmann et al.
patent: 7238807 (2007-07-01), Duran et al.
patent: 7241889 (2007-07-01), Hoffmann et al.
patent: 7332491 (2008-02-01), Grauert et al.
patent: 7371753 (2008-05-01), Stadtmueller et al.
patent: 2002/0183292 (2002-12-01), Pairet et al.
patent: 2002/0183293 (2002-12-01), Banerjee et al.
patent: 2003/0130286 (2003-07-01), Denny et al.
patent: 2004/0029885 (2004-02-01), Bauer et al.
patent: 2004/0147524 (2004-07-01), Bauer et al.
patent: 2004/0176380 (2004-09-01), Hoffmann et al.
patent: 2005/0014760 (2005-01-01), Hoffmann et al.
patent: 2005/0014761 (2005-01-01), Hoffmann et al.
patent: 2005/0148501 (2005-07-01), Palmer et al.
patent: 2005/0159414 (2005-07-01), Nickolaus et al.
patent: 2005/0165010 (2005-07-01), Nickolaus et al.
patent: 2006/0004014 (2006-01-01), Hoffmann et al.
patent: 2006/0009457 (2006-01-01), Hoffmann et al.
patent: 2006/0025411 (2006-02-01), Hoffmann et al.
patent: 2006/0035902 (2006-02-01), Linz et al.
patent: 2006/0035903 (2006-02-01), Mohr et al.
patent: 2006/0046989 (2006-03-01), Grauert et al.
patent: 2006/0047118 (2006-03-01), Stadtmueller et al.
patent: 2006/0052383 (2006-03-01), Grauert et al.
patent: 2006/0058311 (2006-03-01), Munzert et al.
patent: 2006/0074088 (2006-04-01), Munzert et al.
patent: 2006/0079503 (2006-04-01), Schwede et al.
patent: 2008/0108812 (2008-05-01), Grauert et al.
patent: 2008/0113992 (2008-05-01), Grauert et al.
patent: 2008/0171747 (2008-07-01), Hoffman et al.
patent: 2008/0177066 (2008-07-01), Linz et al.
patent: 2008/0194818 (2008-08-01), Grauert et al.
patent: 2008/0293944 (2008-11-01), Hoffmann et al.
patent: 2008/0319190 (2008-12-01), Grauert et al.
patent: 2009/0143379 (2009-06-01), Mohr et al.
patent: 2458699 (2003-03-01), None
patent: 2517020 (2004-09-01), None
patent: 2517010 (2004-11-01), None
patent: 2576290 (2006-02-01), None
patent: 143478 (1984-10-01), None
patent: 347146 (1989-06-01), None
patent: 399856 (1990-03-01), None
patent: 429149 (1990-11-01), None
patent: 2287583 (2007-12-01), None
patent: 96/09045 (1996-03-01), None
patent: 96/34867 (1996-11-01), None
patent: 96/36597 (1996-11-01), None
patent: 98/11893 (1998-03-01), None
patent: 01/19825 (2001-03-01), None
patent: WO 01/19825 (2001-03-01), None
patent: WO 01/19825 (2001-03-01), None
patent: 01/70741 (2001-09-01), None
patent: 01/78732 (2001-10-01), None
patent: 02/057261 (2002-07-01), None
patent: 02/076954 (2002-10-01), None
patent: 02/076985 (2002-10-01), None
patent: WO 03/020722 (2003-03-01), None
patent: 03/093249 (2003-11-01), None
patent: 2004/014899 (2004-02-01), None
patent: WO 2004/076454 (2004-09-01), None
patent: WO 2004/076454 (2004-09-01), None
patent: 2004093848 (2004-11-01), None
patent: 2005/067935 (2005-07-01), None
patent: 2006/018182 (2006-02-01), None
patent: 2006/018185 (2006-02-01), None
patent: 2006/018220 (2006-02-01), None
patent: 2006/018221 (2006-02-01), None
patent: 2006018221 (2006-02-01), None
patent: 2006/021378 (2006-03-01), None
patent: 2007/090844 (2007-08-01), None
patent: 2009/019205 (2009-02-01), None
Background Information for the Oct. 2002 ACPS Meeting, 11 pages.
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, pp. 217-1 (in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227).
Wikipedia, Melting Point, Jan. 2007.
Ghandi, L, et al., “An Open-Label Phase II Trial of the PLK Inhibitor BI 2536 in Patients with Sensitive Relapse Small Cell Lung Cancer”. ASCO Meeting 2009.
ISR-01-1758.
BBC News/Health, Killer Breast Cancern Therapy Hope, www.newsvote.bbc/co./uk, downloaded Mar. 26, 2009.
Blain, S. W. et al., “Differential interaction of the cyclin-dependent kinase (Cdk) Inhibitor p27KIP with cyclin A-Cdk2 and cyclin D2-Cdk4”. The Journal of Biological Chemistry, vol. 272, No. 41, Issue Oct. 10, 1997, pp. 25862-25872.
Leukemia & Lymphoma Society - Disease Information-Lymphoma. www.leukemia-lymphonna—org/all—page? item—id-7030, downloaded Mar. 26, 2009.
Leukemia & Lymphoma Society - Disease Information. www.leukemia-lymphoma.org/all—page?item—id-7026, downloaded Mar. 26, 2009.
MedlinePlus: Bacterial Infections. www.nim.nih.gov/medlineplus/print/bacterialinfections.htm, downloaded Mar. 26, 2009.
MedlinePlus: Viral Infections. www.nim.nih.gov/medlineplus/print/viralinfections.htm, downloaded Mar. 26, 2009.
National Kidney Foundation: Chronic Kidney Disease (CKD). www.kidney.org/kidneydisease/ckd/index.cfm, downloaded Mar. 26, 2009.
Viral Defense Foundation. www.viraldefense.org/mission.htm, downloaded Mar. 26, 2009.
Visiting Nurse Association of America. www.vnaa.org/gen/Germ—Protection—Center—Cold—and—Flu—Resources,html, downloaded Mar. 26, 2009.
Wagner, B. et al, “7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine, a potent inhibitor of cAMP-specificphosphodiesterase, enhancing nuclear protein binding to the CRE consensus sequence in human tumour cells”, Biochemical Pharmacology, Pergamon, Oxford, GB, pp. 659-668.
Organic Chemistry, Grupo Editorial Iberoamerica, Section 13, 3, pp. 301-302, 1983 (best copy available in Spanish).
Office Action mailed Apr. 28, 2004 for U.S. Appl. No. 10/374,876 filed Feb. 26, 2003 (Boehringer Ingelheim).
Office Action mailed Dec. 10, 2003 for U.S. Appl. No. 10/226,710 filed Aug. 23, 2002. (Boehringer Ingelheim).
ACPS Meeting, Background Information. “Scientific considerations of polymorphism in pharmaceutical solds: abbreviated new drug applications”. Oct. 2002.
T. Ahlenius. “List of cardiovascular disorders/diseases”. Ahlenius, Karolinska Institutet. Stockholm, Sweden. Cardiovascular Diseases, p1-34, Apr. 2007.
N. Ahmad. “Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer”. Dept of Dermatology, Univ. Wisconsin, pp. 3-5.
K. Arnold. “Collaboration to play key role in NCI's future, director says”. Journal of the National Cancer Institute, Jun. 5, 2002, pp. 790-792, vol. 94, No. 11.
J. C. Bennett, et al., “Textbook of Medicine”, Part XIV, Oncology, 1997.
Dipolar aprotic solvent. Exhibit A, IUPAC Compendium of Chemical Terminology, 2ndEdition, 1997.
F. Z. Doerwald. “Side reactions in organice synthesis”. 2005.
Eurasian Opinion, Appln No. 2007/00389/28, Maly Slatoustinsky per., d.10, kv.15, 101000 Moscow, Russia, “EVROMARKPAT”, 2007.
G. Ferrand, et al., “Synthesis and potential antiallergic activity of new pteridinones and related compounds”. Eur. J. Med. Chem, 31, 1996, pp. 273-280. XP-2246920.
D. Giron. “Thernal analysis and calorimetric methods in the characterization of plymorphs and solvates”. Thermochimica Acta 248, 1995, pp. 1-59.
Goodman-Gilman's “The Pharmacological Basis of Therapeutics”. Ninth edition, 1996, pp. 1225-1271.
Y. Ito, et al., “Polo-like kinase 1 (PLK) expression is associated with cell proliferative activity and cdc2 expression in malignant-lymphoma of the thyroid”. Cat.Inist.Fr., 2006.
J. Jaworska, et al., “Review of methods for assessing the applicability domains of SARS and QSARS”. Sponsor: the European Commission — Joint Research Ctr., Institute for Health and Consumer Protection —ECVAM, Italy, 2004.
M. K. Kashima, et al., “Expression of polo-like kinase (PLK1) in non-Hodgkin's lymphomas”. NCBI
Herter Rolf
Hoffmann Matthias
Kraemer Gerd F.
Linz Guenter
Rall Werner
Berch Mark L
Boehringer Ingelheim International GmbH
Bottino Anthony P.
Devlin Mary-Ellen M.
Jaisle Cecilia M
LandOfFree
Hydrates and polymorphs of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrates and polymorphs of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrates and polymorphs of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244933